QIAGEN N.V. (QGEN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:QGEN - NL0015002CX3 - Common Stock
45.56 USD
-0.3 (-0.65%)
45.78 USD
+0.22 (+0.48%)
Taking everything into account, QGEN scores 6 out of 10 in our fundamental rating. QGEN was compared to 57 industry peers in the Life Sciences Tools & Services industry. QGEN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QGEN has a decent growth rate and is not valued too expensively. These ratings would make QGEN suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year QGEN was profitable.
In the past year QGEN had a positive cash flow from operations.
In the past 5 years QGEN has always been profitable.
QGEN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
QGEN has a better Return On Assets (6.19%) than 82.46% of its industry peers.
QGEN has a Return On Equity of 11.11%. This is amongst the best in the industry. QGEN outperforms 82.46% of its industry peers.
QGEN has a Return On Invested Capital of 7.44%. This is in the better half of the industry: QGEN outperforms 78.95% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QGEN is significantly below the industry average of 13.99%.
The last Return On Invested Capital (7.44%) for QGEN is above the 3 year average (7.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| ROIC | 7.44% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
With an excellent Profit Margin value of 19.58%, QGEN belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
In the last couple of years the Profit Margin of QGEN has declined.
QGEN has a Operating Margin of 27.02%. This is amongst the best in the industry. QGEN outperforms 96.49% of its industry peers.
QGEN's Operating Margin has improved in the last couple of years.
QGEN's Gross Margin of 64.10% is amongst the best of the industry. QGEN outperforms 85.96% of its industry peers.
QGEN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.02% | ||
| PM (TTM) | 19.58% | ||
| GM | 64.1% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QGEN is destroying value.
Compared to 1 year ago, QGEN has less shares outstanding
Compared to 5 years ago, QGEN has less shares outstanding
Compared to 1 year ago, QGEN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.49 indicates that QGEN is not in any danger for bankruptcy at the moment.
The Altman-Z score of QGEN (3.49) is better than 68.42% of its industry peers.
QGEN has a debt to FCF ratio of 4.50. This is a neutral value as QGEN would need 4.50 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.50, QGEN is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that QGEN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.45, QGEN is doing worse than 61.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.5 | ||
| Altman-Z | 3.49 |
ROIC/WACC0.92
WACC8.07%
2.3 Liquidity
QGEN has a Current Ratio of 2.60. This indicates that QGEN is financially healthy and has no problem in meeting its short term obligations.
QGEN has a Current ratio (2.60) which is in line with its industry peers.
QGEN has a Quick Ratio of 2.30. This indicates that QGEN is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 2.30, QGEN perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.6 | ||
| Quick Ratio | 2.3 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 9.62% over the past year.
The Earnings Per Share has been growing by 8.40% on average over the past years. This is quite good.
QGEN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.32%.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
3.2 Future
QGEN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.54% yearly.
The Revenue is expected to grow by 7.12% on average over the next years.
EPS Next Y9.25%
EPS Next 2Y8.01%
EPS Next 3Y8.58%
EPS Next 5Y9.54%
Revenue Next Year5%
Revenue Next 2Y5.57%
Revenue Next 3Y5.79%
Revenue Next 5Y7.12%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
QGEN is valuated rather expensively with a Price/Earnings ratio of 19.22.
Based on the Price/Earnings ratio, QGEN is valued cheaper than 87.72% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.29. QGEN is valued slightly cheaper when compared to this.
QGEN is valuated rather expensively with a Price/Forward Earnings ratio of 17.58.
89.47% of the companies in the same industry are more expensive than QGEN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.51, QGEN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.22 | ||
| Fwd PE | 17.58 |
4.2 Price Multiples
QGEN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QGEN is cheaper than 92.98% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, QGEN is valued cheaply inside the industry as 85.96% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.91 | ||
| EV/EBITDA | 13.32 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
QGEN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.08
PEG (5Y)2.29
EPS Next 2Y8.01%
EPS Next 3Y8.58%
5. Dividend
5.1 Amount
With a yearly dividend of 0.53%, QGEN is not a good candidate for dividend investing.
QGEN's Dividend Yield is rather good when compared to the industry average which is at 0.46. QGEN pays more dividend than 94.74% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, QGEN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.53% |
5.2 History
QGEN does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.01%
EPS Next 3Y8.58%
45.56
-0.3 (-0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners84.59%
Inst Owner Change-18.51%
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap9.88B
Revenue(TTM)2.07B
Net Income(TTM)405.37M
Analysts74.17
Price Target51.67 (13.41%)
Short Float %2.86%
Short Ratio5.44
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.53% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.14%
Min EPS beat(2)-2.4%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)0.92%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.59%
EPS beat(12)8
Avg EPS beat(12)2.59%
EPS beat(16)12
Avg EPS beat(16)5.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.6%
Revenue beat(12)2
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)0.46%
PT rev (1m)-0.82%
PT rev (3m)-2.18%
EPS NQ rev (1m)-1.26%
EPS NQ rev (3m)-1.96%
EPS NY rev (1m)0.64%
EPS NY rev (3m)1.27%
Revenue NQ rev (1m)-0.9%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)-0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.22 | ||
| Fwd PE | 17.58 | ||
| P/S | 4.77 | ||
| P/FCF | 20.91 | ||
| P/OCF | 15.02 | ||
| P/B | 2.71 | ||
| P/tB | 12.38 | ||
| EV/EBITDA | 13.32 |
EPS(TTM)2.37
EY5.2%
EPS(NY)2.59
Fwd EY5.69%
FCF(TTM)2.18
FCFY4.78%
OCF(TTM)3.03
OCFY6.66%
SpS9.55
BVpS16.83
TBVpS3.68
PEG (NY)2.08
PEG (5Y)2.29
Graham Number29.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| ROCE | 10.03% | ||
| ROIC | 7.44% | ||
| ROICexc | 10.67% | ||
| ROICexgc | 39.98% | ||
| OM | 27.02% | ||
| PM (TTM) | 19.58% | ||
| GM | 64.1% | ||
| FCFM | 22.82% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.5 | ||
| Debt/EBITDA | 2.17 | ||
| Cap/Depr | 97.52% | ||
| Cap/Sales | 8.94% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.76% | ||
| Profit Quality | 116.56% | ||
| Current Ratio | 2.6 | ||
| Quick Ratio | 2.3 | ||
| Altman-Z | 3.49 |
F-Score8
WACC8.07%
ROIC/WACC0.92
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
EPS Next Y9.25%
EPS Next 2Y8.01%
EPS Next 3Y8.58%
EPS Next 5Y9.54%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
Revenue Next Year5%
Revenue Next 2Y5.57%
Revenue Next 3Y5.79%
Revenue Next 5Y7.12%
EBIT growth 1Y18.55%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year56.15%
EBIT Next 3Y22.11%
EBIT Next 5Y15.78%
FCF growth 1Y71.67%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y52.1%
OCF growth 3Y1.77%
OCF growth 5Y15.28%
QIAGEN N.V. / QGEN FAQ
Can you provide the ChartMill fundamental rating for QIAGEN N.V.?
ChartMill assigns a fundamental rating of 6 / 10 to QGEN.
What is the valuation status of QIAGEN N.V. (QGEN) stock?
ChartMill assigns a valuation rating of 6 / 10 to QIAGEN N.V. (QGEN). This can be considered as Fairly Valued.
What is the profitability of QGEN stock?
QIAGEN N.V. (QGEN) has a profitability rating of 8 / 10.
What are the PE and PB ratios of QIAGEN N.V. (QGEN) stock?
The Price/Earnings (PE) ratio for QIAGEN N.V. (QGEN) is 19.22 and the Price/Book (PB) ratio is 2.71.